A. Kaplan-Meier curves of Progression Free Survival of CPB (carboplatin, paclitaxel, and bevacizumab) versus CPBE (carboplatin, paclitaxel, and bevacizumab plus everolimus)
B. Kaplan-Meier curves of Overall Survival of CPB (carboplatin, paclitaxel, and bevacizumab) versus CPBE (carboplatin, paclitaxel, and bevacizumab plus everolimus)